Volitional Help Sheets to Support Smoking Cessation in Clinical Care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, single-blind interventional study in the tobacco treatment department at Clinique de la Mitterie. Participants who have just completed their first tobacco treatment consultation are randomized to receive either usual care plus a smoking-specific volitional help sheet or usual care alone. The volitional help sheet guides patients to create personalized if-then plans that link tempting situations to coping strategies. Outcomes will be assessed to see if the tool enhances adherence to treatment plans and supports behavior change in a clinical setting. The study focuses on French-speaking adults affiliated with a social security scheme eligible for informed consent.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who have just completed their first consultation in the tobacco treatment department at the Clinique de la Mitterie.
* Ability to understand written and spoken French.
* Affiliation with a social security scheme.
* Provision of informed consent.

Exclusion Criteria:

* None

Where it's running

• Clinique la Mitterie
  Lille, France Recruiting

Study contacts

• Study coordinator: Michaël RACODON, Ph.D
• Email: mracodon@clinique-mitterie.com
• Phone: +33320223457

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Extended tobacco support for people experiencing homelessness

  This program tests whether extending tobacco treatment to 6 months with pharmacist counseling, monthly nicotine replacement deliveries, and phone wellness coaching helps adults experiencing homelessness quit smoking compared with a 3-month package.

  Recruiting Phase 4 University of California, San Francisco · San Francisco, California · NCT07148232

• Semaglutide to help people with type 2 diabetes quit smoking

  This pilot will test whether adding semaglutide to combination nicotine replacement helps adults with type 2 diabetes quit smoking and limits post-quit weight gain.

  Recruiting Phase 3 Ottawa Heart Institute Research Corporation · Ottawa, Ontario · NCT07059377

• Varenicline-based approach to help Veterans who smoke see if they can reduce smoking and try to quit

  This study tests whether varenicline, plus motivational support, helps Veterans who aren’t ready to quit reduce smoking and make quit attempts.

  Recruiting at 3 sites Phase 4 VA Office of Research and Development · San Diego, California and 3 other locations · NCT06966362

• A program to help people quit smoking using CBT and mindfulness audio support

  This study is testing if combining text messages for quitting smoking with mindfulness audio support helps people stop smoking better than just using text messages alone.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou · NCT06901713

• Quitting Matters: a smoking quit program for people living with HIV

  This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT06883097

• Improving tobacco cessation support for patients in poverty in Utah

  This study is testing new ways to help people living in poverty in Utah quit smoking by using support tools and strategies in their healthcare clinics.

  Recruiting University of Utah · Salt Lake City, Utah · NCT06881069

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.